trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol

C14H23N3O2 — CID 95827633

IUPACtrans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol
SMILESCc1nnc(C2CCN([C@@H]3CCCC[C@H]3O)CC2)o1
InChIInChI=1S/C14H23N3O2/c1-10-15-16-14(19-10)11-6-8-17(9-7-11)12-4-2-3-5-13(12)18/h11-13,18H,2-9H2,1H3/t12-,13-/m1/s1
InChIKeyYXJYMIZPLSQURK-CHWSQXEVSA-N
MW265.36 g/mol
LogP1.86
Rot. Bonds2

About trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol

trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol (PubChem CID 95827633) has the molecular formula C14H23N3O2 and a molecular weight of 265.36 g/mol. Its IUPAC name is trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol.

Molecular Properties

Compound Nametrans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol
PubChem CID95827633
Molecular FormulaC14H23N3O2
Molecular Weight265.36 g/mol
Exact Mass265.18
IUPAC Nametrans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol
SMILESCc1nnc(C2CCN([C@@H]3CCCC[C@H]3O)CC2)o1
InChIInChI=1S/C14H23N3O2/c1-10-15-16-14(19-10)11-6-8-17(9-7-11)12-4-2-3-5-13(12)18/h11-13,18H,2-9H2,1H3/t12-,13-/m1/s1
InChIKeyYXJYMIZPLSQURK-CHWSQXEVSA-N
XLogP1.86
TPSA62.39 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500265.36
LogP ≤ 51.86
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-cyclohexyl-5-methyl-1,3,4-oxadiazole;methanamine
CID 143346929
2-cyclohexyl-5-methyl-1,3,4-oxadiazole;propane
CID 153404775
2-(1-cyclopentylsulfonylpiperidin-4-yl)-5-methyl-1,3,4-oxadiazole
CID 110421409
trans-(1S,2S)-2-[4-(4-methylphenyl)piperidin-1-yl]cyclohexan-1-ol
CID 132850025
N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide
CID 110603715
cis-(1S,2R)-2-(4-methylpiperazin-1-yl)cyclohexan-1-ol
CID 129365578
trans-(1R,2R)-2-(4-methylpiperazin-1-yl)cyclohexan-1-ol
CID 13447994
2-methyl-5-(1-methylsulfonylpiperidin-4-yl)-1,3,4-oxadiazole
CID 73439255
cis-(1S,2R)-2-pyrrolidin-1-ylcyclohexan-1-ol
CID 23656399
trans-(1R,2R)-2-pyrrolidin-1-ylcyclohexan-1-ol
CID 10103566
1-ethyl-7-(5-methyl-1,3,4-oxadiazol-2-yl)azonan-2-one
CID 123598825
cis-(1R,2S)-2-piperidin-1-ylcyclododecan-1-ol
CID 124555057

Frequently Asked Questions

What is the IUPAC name of trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol?
The IUPAC name of trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol (CID 95827633) is trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol.
What is the SMILES notation for trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol?
The canonical SMILES for trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol is Cc1nnc(C2CCN([C@@H]3CCCC[C@H]3O)CC2)o1.
What is the InChIKey of trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol?
The InChIKey is YXJYMIZPLSQURK-CHWSQXEVSA-N. The full InChI is InChI=1S/C14H23N3O2/c1-10-15-16-14(19-10)11-6-8-17(9-7-11)12-4-2-3-5-13(12)18/h11-13,18H,2-9H2,1H3/t12-,13-/m1/s1.
What are the key properties of trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol?
trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol has a molecular weight of 265.36 g/mol, XLogP of 1.86, 2 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol is sourced from PubChem (CID 95827633), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).